DocGo (NASDAQ:DCGO – Get Free Report) will likely be releasing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect DocGo to post earnings of ($0.0975) per share and revenue of $75.35 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 13, 2026 at 5:00 PM ET.
DocGo (NASDAQ:DCGO – Get Free Report) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.10). The company had revenue of $75.55 million for the quarter, compared to analyst estimates of $72.48 million. DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. On average, analysts expect DocGo to post $-0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
DocGo Stock Performance
DocGo stock opened at $0.65 on Tuesday. DocGo has a 1 year low of $0.45 and a 1 year high of $1.78. The company’s 50 day simple moving average is $0.59 and its 200-day simple moving average is $0.65. The company has a market capitalization of $64.02 million, a price-to-earnings ratio of -0.34 and a beta of 0.99.
Hedge Funds Weigh In On DocGo
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on DCGO shares. Wall Street Zen upgraded DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $2.38.
Check Out Our Latest Research Report on DocGo
About DocGo
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
